Engineers Gate Manager’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-9,990
Closed -$239K 2221
2021
Q1
$239K Buy
+9,990
New +$186K 0.01% 1483
2020
Q4
Sell
-57,382
Closed -$815K 2122
2020
Q3
$815K Sell
57,382
-86,822
-60% -$1.33M 0.04% 729
2020
Q2
$2.12M Buy
+144,204
New +$1.47M 0.11% 251
2020
Q1
Sell
-37,340
Closed -$180K 2080
2019
Q4
$180K Buy
37,340
+5,459
+17% +$30.1K 0.01% 1490
2019
Q3
$193K Sell
31,881
-8,684
-21% -$54.2K 0.01% 1214
2019
Q2
$264K Sell
40,565
-11,468
-22% -$80.8K 0.01% 904
2019
Q1
$369K Buy
+52,033
New +$343K 0.02% 686
2018
Q4
Sell
-28,951
Closed -$213K 1236
2018
Q3
$213K Buy
+28,951
New +$212K 0.02% 728

Engineers Gate Manager's GNMK Position: Q2 2021 in Review

Engineers Gate Manager sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 9,990 shares — an estimated $239K sold.

Engineers Gate Manager first reported a position in GNMK in Q3 2018 and held it in 8 quarters. The position peaked at $2.12M in Q2 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Engineers Gate Manager reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Engineers Gate Manager sold 9,990 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $239K.
  • Engineers Gate Manager first reported a position in GenMark Diagnostics, Inc in Q3 2018 and held it in 8 quarters.
  • Engineers Gate Manager's GenMark Diagnostics, Inc position peaked at $2.12M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Engineers Gate Manager's 13F filing for Q2 2021, filed 16 Aug 2021.